EPIRUS Biopharma: Epirus Biopharmaceuticals, Inc. Files SEC Form 8-K, Current Report (Jun. 14, 2016)

By a News Reporter-Staff News Editor at Drug Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Epirus Biopharmaceuticals, Inc. (Form 8-K) was posted on Ju